Eikon TherapeuticsEIKN 13F holders, Q1 2026 (March 31) 52 holders
3 famous investors
$10.58 avg. 13F price*
At the end of Q1 2026 , 52 institutions reported holding Eikon Therapeutics Inc. (EIKN) in their 13F filings. The largest holders were FMR LLC ($40.6M), BlackRock, Inc. ($35.1M) and Foresite Capital Management IV, LLC ($20.6M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
Company Eikon Therapeutics Inc.
CUSIP 282564103
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2026 Institutions Total Value New Positions 48 $239.3M Exits 0 $0
Ownership 52 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ FMR LLC 0.00% New 3,836,830 $40.6M BlackRock, Inc. 0.00% New 3,319,379 $35.1M Foresite Capital Management IV, LLC 8.67% New 1,943,682 $20.6M Merck & Co., Inc. 5.05% New 1,666,666 $17.6M Foresite Capital Management V, LLC 5.15% New 1,318,983 $14.0M T. Rowe Price Investment Management, Inc. 0.01% New 1,222,487 $12.9M Capital World Investors 0.00% New 1,143,637 $12.1M Alliancebernstein L.P. 0.00% New 1,022,188 $10.8M T. Rowe Price Associates Inc. 0.00% New 975,834 $10.3M Vanguard Capital Management LLC 0.00% — 969,431 $10.3M EcoR1 Capital, LLC 0.33% New 732,606 $7.8M Baker Bros. Advisors LP 0.03% New 555,555 $5.9M Soros Capital Management LLC 2.23% New 484,672 $5.1M StepStone Group LP 2.02% New 395,340 $4.2M Canada Pension Plan Investment Board 0.00% New 379,024 $4.0M Franklin Resources Inc. 0.00% New 350,000 $3.7M Citadel Advisors 0.00% New 310,000 $3.3M General Catalyst Group Management, LLC 1.76% New 305,233 $3.2M Geode Capital Management, LLC 0.00% New 273,931 $2.9M Jane Street Group, LLC 0.00% New 265,000 $2.8M Ensign Peak Advisors, Inc 0.00% New 200,000 $2.1M Wellington Management Group LLP 0.00% New 185,000 $2.0M Millennium Management 0.00% New 175,627 $1.9M Blackstone Inc. 0.01% New 168,338 $1.8M BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.00% New 140,344 $1.5M Vanguard Fiduciary Trust Co. 0.00% — 131,954 $1.4M Charles Schwab Investment Management Inc. 0.00% New 131,079 $1.4M Goldman Sachs Group Inc. 0.00% New 129,306 $1.4M Comprehensive Financial Management LLC 0.04% New 116,276 $1.2M Burkehill Global Management, LP 0.06% New 115,000 $1.2M LMR Partners LLP 0.01% New 115,000 $1.2M UBS Group AG 0.00% New 99,408 $1.1M Bank of America Corp. 0.00% New 86,134 $911K Seven Grand Managers, LLC 0.06% New 80,000 $846K Ghisallo Capital Management LLC 0.02% New 70,000 $741K TD Asset Management Inc 0.00% New 57,074 $604K Northern Trust Corp. 0.00% New 45,531 $482K State Street Corp. 0.00% New 40,150 $425K Squarepoint Ops LLC 0.00% New 30,978 $328K Manufacturers Life Insurance Company, The 0.00% New 28,623 $303K XTX Topco Ltd 0.00% New 26,056 $276K Axq Capital, LP 0.02% New 15,408 $163K Morgan Stanley 0.00% New 15,273 $162K Tudor Investment Corporation 0.00% New 15,000 $159K Vanguard Global Advisers, LLC 0.00% — 13,747 $145K Vanguard Portfolio Management LLC 0.00% — 13,613 $144K Hudson Bay Capital Management LP 0.00% New 13,480 $143K Landscape Capital Management, L.L.C. 0.01% New 10,381 $110K JPMorgan Chase & Co. 0.00% New 1,300 $13K Tower Research Capital LLC (TRC) 0.00% New 1,139 $12K Quantbot Technologies LP 0.00% New 1,098 $12K Barclays PLC 0.00% New 318 $3K
"% of holder's portfolio" is EIKN's weight in each manager's 13F, not the share of Eikon Therapeutics Inc. the manager owns.